Nanomaterials as non-viral siRNA delivery agents for cancer therapy

BioImpacts

Volumn 3, Issue 2, 2013, Pages 53-65

  Singh, Sanjay ^a  

^a AHMEDABAD UNIVERSITY   (India)

Author keywords

Cancer nanotechnology; Cancer therapy; Gene delivery; Nanomaterials; Nanomedicines

Indexed keywords

CARBON NANOTUBE; DENDRIMER; DEXTRAN; FERRIC SULFATE; FULLERENE DERIVATIVE; GOLD NANOPARTICLE; GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; MAGNETIC NANOPARTICLE; MATRIX METALLOPROTEINASE; MESSENGER RNA; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NANOSHELL; POLYMER; QUANTUM DOT; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BREAST CANCER; CANCER GENE THERAPY; DNA TRANSFECTION; HUMAN; HYDROPHOBICITY; INTERNALIZATION; LIPID BILAYER; MOLECULAR WEIGHT; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PERMEABILITY; PHOTOCHEMISTRY; PHYSICAL CHEMISTRY; PROTEIN CLEAVAGE; RNA STABILITY; TUMOR XENOGRAFT;

EID: 84881502609     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2013.007     Document Type: Article

References (110)

1. Xiao PJ, Lentz TB, Samulski RJ. Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector. Ther Deliv 2012;3:835-56.
2. Young LS, Searle PF, Onion D, Mautner V. Viral gene therapy strategies: from basic science to clinical application. J Pathol 2006;208:299-318.
3. Di Matteo M, Belay E, Chuah MK, Vandendriessche T. Recent developments in transposon-mediated gene therapy. Expert Opin Biol Ther 2012;12:841-58.
4. DeVincenzo JP. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses. Antivir Ther 2012;17:213-25.
5. Jang JH, Schaffer DV, Shea LD. Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther 2011;19:1407-15.
6. Jia LT, Chen SY, Yang AG. Cancer gene therapy targeting cellular apoptosis machinery. Cancer Treat Rev 2012;38:868-76.
7. Seth S, Johns R, Templin MV. Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects. Ther Deliv 2012;3:245-61.
8. Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 2012;11:125-40.
9. Murakami T, Sunada Y. Plasmid DNA gene therapy by electroporation: principles and recent advances. Curr Gene Ther 2011;11:447-56.
10. Li Y, Wang J, Satterle A, Wu Q, Liu F. Gene transfer to skeletal muscle by site-specific delivery of electroporation and ultrasound. Biochem Biophys Res Commun 2012;424:203-7.
11. Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004;11:1363-9.
12. Shen H, Sun T, Ferrari M. Nanovector delivery of siRNA for cancer therapy. Cancer Gene Ther 2012;19:367-73.
13. Liu C, Zhang N. Nanoparticles in gene therapy principles, prospects, and challenges. Prog Mol Biol Transl Sci 2011;104:509-62.
14. Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 2006;12:1317-24.
15. Singh S, Sharma A, Robertson GP. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res 2012;72:5663-8.
16. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, et al. Size-Dependent Cytotoxicity of Gold Nanoparticles. Small 2007;3:1941-9.
17. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 2002;6:829-34.
18. Li J, Huang L. Targeted delivery of RNAi therapeutics for cancer therapy. Nanomedicine (Lond) 2010;5:1483-6.
19. McNeil SE. Nanotechnology for the biologist. J Leukoc Biol 2005;78:585-94.
20. Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res 2012;45:1153-62.
21. Mah SM, Buske C, Humphries RK, Kuchenbauer F. miRNA*: a passenger stranded in RNA-induced silencing complex? Crit Rev Eukaryot Gene Expr 2010;20:141-8.
22. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006;1:297-315.
23. Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep 2002;22:197-224.
24. Yan X, Scherphof GL, Kamps JA. Liposome opsonization. J Liposome Res 2005;15:109-39.
25. Accardo A, Mansi R, Salzano G, Morisco A, Aurilio M, Parisi A, et al. Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells. J Drug Target 2012.
26. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004;10:310-5.
27. Sasaki K, Kogure K, Chaki S, Nakamura Y, Moriguchi R, Hamada H, et al. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 2008;391:2717-27.
28. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005;4:581-93.
29. Khalil IA, Kogure K, Futaki S, Hama S, Akita H, Ueno M, et al. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther 2007;14:682-9.
30. Kogure K, Akita H, Harashima H. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging. J Control Release 2007;122:246-51.
31. Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, et al. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. ACS Nano 2012;6:4955-65.
32. Ciftci K, Levy RJ. Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int J Pharm 2001;218:81-92.
33. Katav T, Liu L, Traitel T, Goldbart R, Wolfson M, Kost J. Modified pectin-based carrier for gene delivery: cellular barriers in gene delivery course. J Control Release 2008;130:183-91.
34. Berg K, Selbo PK, Prasmickaite L, Hogset A. Photochemical drug and gene delivery. Curr Opin Mol Ther 2004;6:279-87.
35. Kusumoto K, Akita H, El-Sayed A, Harashima H. Effect of the anchor in polyethylene glycol-lipids on the transfection activity of PEGylated cationic liposomes encapsulating DNA. Biol Pharm Bull 2012;35:445-8.
36. Germershaus O, Merdan T, Bakowsky U, Behe M, Kissel T. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. Bioconjug Chem 2006;17:1190-9.
37. He XW, Liu T, Chen YX, Cheng DJ, Li XR, Xiao Y, et al. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther 2008;15:193-202.
38. Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 2005;19:1978-85.
39. Mendonca LS, Firmino F, Moreira JN, Pedroso de Lima MC, Simoes S. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Bioconjug Chem 2010;21:157-68.
40. Wang S, Low PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 1998;53:39-48.
41. Youn JI, Park SH, Jin HT, Lee CG, Seo SH, Song MY, et al. Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Ther 2008;15:703-12.
42. Rao KS, Reddy MK, Horning JL, Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 2008;29:4429-38.
43. Schmidt N, Mishra A, Lai GH, Wong GC. Arginine-rich cell-penetrating peptides. FEBS Lett. 2010 May 3;584(9):1806-13.
44. Jiang QY, Lai LH, Shen J, Wang QQ, Xu FJ, Tang GP. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. Biomaterials 2011;32:7253-62.
45. Hatakeyama H, Akita H, Ito E, Hayashi Y, Oishi M, Nagasaki Y, et al. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid. Biomaterials 2011;32:4306-16.
46. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res 2011;44:947-56.
47. Huschka R, Barhoumi A, Liu Q, Roth JA, Ji L, Halas NJ. Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano 2012;6:7681-91.
48. Braun GB, Pallaoro A, Wu G, Missirlis D, Zasadzinski JA, Tirrell M, et al. Laser-Activated Gene Silencing via Gold Nanoshell-siRNA Conjugates. ACS Nano 2009;3:2007-15.
49. Arbogast JW, Darmanyan AP, Foote CS, Diederich FN, Whetten RL, Rubin Y, et al. Photophysical properties of sixty atom carbon molecule (C60). The Journal of Physical Chemistry 1991;95:11-12.
50. Xie Q, Perez-Cordero E, Echegoyen L. Electrochemical detection of C606-and C706-: Enhanced stability of fullerides in solution. Journal of the American Chemical Society 1992;114:3978-80.
51. Nakamura E, Isobe H. Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc Chem Res 2003;36:807-15.
52. Strom TA, Barron AR. A simple quick route to fullerene amino acid derivatives. Chem Commun (Camb) 2010;46:4764-6.
53. Maeda-Mamiya R, Noiri E, Isobe H, Nakanishi W, Okamoto K, Doi K, et al. In vivo gene delivery by cationic tetraamino fullerene. Proc Natl Acad Sci U S A 2010;107:5339-44.
54. Isobe H, Sugiyama S, Fukui Ki K, Iwasawa Y, Nakamura E. Atomic Force Microscope Studies on Condensation of Plasmid DNA with Functionalized Fullerenes This research was supported by Grant-in-Aid for Specially Promoted Research from Ministry of Education, Culture, Sports, Science, and Technology. Angew Chem Int Ed Engl 2001;40:3364-7.
55. Isobe H, Nakanishi W, Tomita N, Jinno S, Okayama H, Nakamura E. Gene delivery by aminofullerenes: structural requirements for efficient transfection. Chem Asian J 2006;1:167-75.
56. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res 2008;41:60-8.
57. Liu M, Chen B, Xue Y, Huang J, Zhang L, Huang S, et al. Polyamidoamine-grafted multiwalled carbon nanotubes for gene delivery: synthesis, transfection and intracellular trafficking. Bioconjug Chem. 2011 Nov 16;22(11):2237-43.
58. Al-Jamal KT, Gherardini L, Bardi G, Nunes A, Guo C, Bussy C, et al. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci U S A 2011;108:10952-7.
59. Neves V, Heister E, Costa S, Tilmaciu C, Flahaut E, Soula B, et al. Design of double-walled carbon nanotubes for biomedical applications. Nanotechnology 2012;23:365102.
60. Sanz V, Coley HM, Silva SR, McFadden J. Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubes. J Nanosci Nanotechnol 2012;12:1739-47.
61. Chen H, Ma X, Li Z, Shi Q, Zheng W, Liu Y, et al. Functionalization of single-walled carbon nanotubes enables efficient intracellular delivery of siRNA targeting MDM2 to inhibit breast cancer cells growth. Biomed Pharmacother 2012;66:334-8.
62. Qin W, Yang K, Tang H, Tan L, Xie Q, Ma M, et al. Improved GFP gene transfection mediated by polyamidoamine dendrimer-functionalized multi-walled carbon nanotubes with high biocompatibility. Colloids Surf B Biointerfaces 2011;84:206-13.
63. Bussy C, Ali-Boucetta H, Kostarelos K. Safety Considerations for Graphene: Lessons Learnt from Carbon Nanotubes. Acc Chem Res 2013;46:692-701.
64. Kobayashi E, Iyer AK, Hornicek FJ, Amiji MM, Duan Z. Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study. Clin Orthop Relat Res 2013;471:915-25.
65. Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, et al. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One 2010;5:e10764.
66. Briane D, Slimani H, Tagounits A, Naejus R, Haddad O, Coudert R, et al. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. J Drug Target 2012;20:347-54.
67. Kim HK, Davaa E, Myung CS, Park JS. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int J Pharm 2010;392:141-7.
68. Sitharaman B, Zakharian TY, Saraf A, Misra P, Ashcroft J, Pan S, et al. Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors. Mol Pharm 2008;5:567-78.
69. Wang L, Shi J, Zhang H, Li H, Gao Y, Wang Z, et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 2013;34:262-74.
70. Liu H, Wang H, Yang W, Cheng Y. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. J Am Chem Soc 2012;134:17680-7.
71. Briz V, Serramia MJ, Madrid R, Hameau A, Caminade AM, Majoral JP, et al. Validation of a Generation 4 Phosphorus-Containing Polycationic Dendrimer for Gene Delivery against HIV-1. Curr Med Chem 2012;19:5044-51.
72. Shao D, Zeng Q, Fan Z, Li J, Zhang M, Zhang Y, et al. Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots. Biomaterials 2012;33:4336-44.
73. Li JM, Zhao MX, Su H, Wang YY, Tan CP, Ji LN, et al. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging. Biomaterials 2011;32:7978-87.
74. Conde J, Ambrosone A, Sanz V, Hernandez Y, Marchesano V, Tian F, et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 2012;6:8316-24.
75. Han L, Zhao J, Zhang X, Cao W, Hu X, Zou G, et al. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano 2012;6:7340-51.
76. Liu Y, Shi M, Xu M, Yang H, Wu C. Multifunctional nanoparticles of Fe(3)O(4)@SiO(2)(FITC)/PAH conjugated the recombinant plasmid of pIRSE2-EGFP/VEGF(165) with dual functions for gene delivery and cellular imaging. Expert Opin Drug Deliv 2012;9:1197-207.
77. Qi L, Wu L, Zheng S, Wang Y, Fu H, Cui D. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules 2012;13:2723-30.
78. Tang Y, Li YB, Wang B, Lin RY, van Dongen M, Zurcher DM, et al. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm 2012;9:1812-21.
79. Yu T, Liu X, Bolcato-Bellemin AL, Wang Y, Liu C, Erbacher P, et al. An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo. Angew Chem Int Ed Engl 2012;51:8478-84.
80. Hayashi Y, Mori Y, Higashi T, Motoyama K, Jono H, Sah DW, et al. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/alpha-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy. Amyloid 2012;19:47-9.
81. Lee JB, Hong J, Bonner DK, Poon Z, Hammond PT. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater 2012;11:316-22.
82. Liu J, Zhou J, Luo Y. SiRNA delivery systems based on neutral cross-linked dendrimers. Bioconjug Chem 2012;23:174-83.
83. Pons T, Mattoussi H. Investigating biological processes at the single molecule level using luminescent quantum dots. Ann Biomed Eng 2009;37:1934-59.
84. Yin F, Gao Y, Chen C, Wu G. [Toxicological study of quantum dots]. Wei Sheng Yan Jiu 2008;37:760-3.
85. Lai L, Lin C, Xiao CQ, Xu ZQ, Han XL, Fu L, et al. Adhesion of quantum dots-induced membrane damage of Escherichia coli. J Colloid Interface Sci 2013;389:61-70.
86. Zhao MX, Li JM, Du L, Tan CP, Xia Q, Mao ZW, et al. Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with beta-cyclodextrin coupled to amino acids. Chemistry. 2011 Apr 26;17(18):5171-9.
87. Jung J, Solanki A, Memoli KA, Kamei K, Kim H, Drahl MA, et al. Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. Angew Chem Int Ed Engl 2010;49:103-7.
88. Subramaniam P, Lee SJ, Shah S, Patel S, Starovoytov V, Lee KB. Generation of a library of non-toxic quantum dots for cellular imaging and siRNA delivery. Adv Mater 2012;24:4014-9.
89. Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA. Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 2010;49:3280-94.
90. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005;21:10644-54.
91. Guo S, Huang Y, Jiang Q, Sun Y, Deng L, Liang Z, et al. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010;4:5505-11.
92. Fliss DM, Kraus M, Tovi F. Adenoid cystic carcinoma of the external auditory canal. Ear Nose Throat J 1990;69:635,8-9,42 passim.
93. Park K, Lee MY, Kim KS, Hahn SK. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 2010;31:5258-65.
94. Arvizo RR, Giri K, Moyano D, Miranda OR, Madden B, McCormick DJ, et al. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One 2012;7:e33650.
95. DeLong RK, Akhtar U, Sallee M, Parker B, Barber S, Zhang J, et al. Characterization and performance of nucleic acid nanoparticles combined with protamine and gold. Biomaterials 2009;30:6451-9.
96. Lee SK, Han MS, Asokan S, Tung CH. Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small 2011;7:364-70.
97. Rhim WK, Kim JS, Nam JM. Lipid-gold-nanoparticle hybrid-based gene delivery. Small 2008;4:1651-5.
98. Visaria RK, Griffin RJ, Williams BW, Ebbini ES, Paciotti GF, Song CW, et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 2006;5:1014-20.
99. Mahajan SD, Aalinkeel R, Reynolds JL, Nair B, Sykes DE, Bonoiu A, et al. Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol Invest 2012;41:337-55.
100. Zhang W, Meng J, Ji Y, Li X, Kong H, Wu X, et al. Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system. Nanoscale 2011;3:3923-32.
101. Xiao Y, Jaskula-Sztul R, Javadi A, Xu W, Eide J, Dammalapati A, et al. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. Nanoscale 2012;4:7185-93.
102. Chang YT, Liao PY, Sheu HS, Tseng YJ, Cheng FY, Yeh CS. Near-infrared light-responsive intracellular drug and siRNA release using au nanoensembles with oligonucleotide-capped silica shell. Adv Mater 2012;24:3309-14.
103. Mok H, Veiseh O, Fang C, Kievit FM, Wang FY, Park JO, et al. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. Mol Pharm 2010;7:1930-9.
104. Lee S, Shim G, Kim S, Kim YB, Kim CW, Byun Y, et al. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes. Nucleic Acid Ther 2011;21:165-72.
105. Prijic S, Sersa G. Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol 2011;45:1-16.
106. Namiki Y. Synthesis of lipidic magnetic nanoparticles for nucleic Acid delivery. Methods Mol Biol 2013;948:243-50.
107. Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, Koido S, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol 2009;4:598-606.
108. Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 2006;13:283-7.
109. Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv 2011;8:59-69.
110. Wang H, Zhang S, Liao Z, Wang C, Liu Y, Feng S, et al. PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier. Biomaterials 2010;31:6589-96.